About Eurogentec
Eurogentec is a company based in Seraing (Belgium) founded in 1985 was acquired by Kaneka in June 2010.. The company has 426 employees as of March 31, 2023. Eurogentec has completed 1 acquisition, including AnaSpec. Eurogentec offers products and services including Oligos, PCR Kits, Antibodies, and Peptides. Eurogentec operates in a competitive market with competitors including Nephron Pharmaceuticals, Enzene Biosciences, Hybio Pharmaceutical, AmbioPharm and Suanfarma, among others.
- Headquarter Seraing, Belgium
- Employees 426 as on 31 Mar, 2023
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Kaneka Eurogentec
-
Annual Revenue
$113.57 M (USD)21as on Mar 31, 2023
-
Net Profit
$14.39 M (USD)24as on Mar 31, 2023
-
EBITDA
$27.36 M (USD)26as on Mar 31, 2023
-
Latest Funding Round
$51.55 K (USD), Grant
Sep 01, 2023
-
Investors
European Union
& 1 more
-
Employee Count
426
as on Mar 31, 2023
- Investments & Acquisitions
-
Acquired by
Kaneka
(Jun 15, 2010)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Eurogentec
Eurogentec offers a comprehensive portfolio of products and services, including Oligos, PCR Kits, Antibodies, and Peptides. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Custom synthesized oligonucleotides for research and diagnostics applications.
Kits for quantitative PCR assays in gene analysis.
Custom polyclonal and monoclonal antibodies for protein detection.
Synthesized peptides for research and therapeutic uses.
Funding Insights of Eurogentec
- Total Funding Total Funding
- Total Rounds 6
- Last Round Grant — $51,549
-
First Round
First Round
(26 Oct 2015)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2023 | Amount | Grant - Eurogentec | Valuation |
investors |
|
| Feb, 2022 | Amount | Grant - Eurogentec | Valuation |
investors |
|
| Dec, 2020 | Amount | Grant - Eurogentec | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Eurogentec
Eurogentec has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include European Union and Kaneka. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Founded Year | Domain | Location | |
|
Chemical products are produced for diverse industrial applications.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Eurogentec
Eurogentec has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include AnaSpec. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Premier provider of reagents and services for research, HTP screening, and drug discovery. Services include peptide/oligo synthesis, Ab prod., and assay dev.
|
1993 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Eurogentec
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Eurogentec Comparisons
Competitors of Eurogentec
Eurogentec operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Nephron Pharmaceuticals, Enzene Biosciences, Hybio Pharmaceutical, AmbioPharm and Suanfarma, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Sterile pharmaceutical products are manufactured and contract services are provided.
|
|
| domain | founded_year | HQ Location |
Company specializing in development of Biosimilars
|
|
| domain | founded_year | HQ Location |
Polypeptide drugs and APIs are developed and manufactured.
|
|
| domain | founded_year | HQ Location |
CDMO and analytical services for peptide development are provided.
|
|
| domain | founded_year | HQ Location |
Generics, nutraceuticals, and APIs are developed by Suanfarma.
|
|
| domain | founded_year | HQ Location |
Biotech company developing personalized medicines for cardiovascular diseases
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Eurogentec
Frequently Asked Questions about Eurogentec
When was Eurogentec founded?
Eurogentec was founded in 1985 and raised its 1st funding round 30 years after it was founded.
Where is Eurogentec located?
Eurogentec is headquartered in Seraing, Belgium. It is registered at Seraing, Liege, Belgium.
How many employees does Eurogentec have?
As of Mar 31, 2023, the latest employee count at Eurogentec is 426.
What is the annual revenue of Eurogentec?
Annual revenue of Eurogentec is $113.57M as on Mar 31, 2023.
What does Eurogentec do?
Eurogentec S.A., is a leading global supplier of innovative reagents, kits, specialty products and custom services. It has three inter-related business units (BU). Life Science Research BU is specialized in innovative solutions in Genomics and Proteomics, through which it supplies a wide range of reagents, kits and consumables for Life Science applications such as Custom Oligonucleotides, high performance PCRqPCR Kits Reagents, catalogue dyes, peptides antibodies. It also offers custom synthesis of petides and antibodies. The Diagnostic Services BU provides technical and project support for contract manufacturing of GMP oligonucleotides and Taq DNA polymerases. The GMP BioManufacturing BU is a US FDA inspected full-service Contract Manufacturing Organization (CMO). It offers expertise in technology transfer, process development, scale-up and cGMP manufacturing of proteins, protein conjugates, plasmid DNA and bacterial vaccines for pre-clinical, clinical and commercial uses. They claim to be experts in microbial cell lines (E.coli, P. pastoris etc.,) and also to have developed over 100 different GMP biopharmaceuticals since 1994. In 2009, Eurogentec acquired AnaSpec, a provider of integrated proteomics solutions for life science research and diagnostics. In 2010, Eurogentec became part of Kaneka Corporation, Osaka, Japan, a chemical company active in polymers, fermentation, biotechnology and electronics, as well as other fields.
Who are the top competitors of Eurogentec?
Eurogentec's top competitors include Nephron Pharmaceuticals, Suanfarma and Enzene Biosciences.
What products or services does Eurogentec offer?
Eurogentec offers Oligos, PCR Kits, Antibodies, and Peptides.
How many acquisitions has Eurogentec made?
Eurogentec has made 1 acquisition, including AnaSpec.
Who are Eurogentec's investors?
Eurogentec has 2 investors. Key investors include European Union, and Kaneka.